01

Glenmark Pharma hits record high after $2B licensing deal for cancer drug

02

Barrick CEO remains bullish on copper amid US tariff uncertainty

03

Asian markets trade mixed as Trump’s tariffs weigh; Nikkei, Kospi end in red